All-trans retinoic acid (ATRA) in prevention and cancer therapy;Kwas całkowicie trans-retinowy (ATRA) w prewencji i terapii nowotworów

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 284-290

  Hoffman, Ewelina ^a   Mielicki, Wojciech P ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

All trans retinoic acid; Retinoic acid receptors RARs; RXRs

Indexed keywords

ANTINEOPLASTIC AGENT; RETINOIC ACID;

HUMAN; NEOPLASM; REVIEW;

ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; TRETINOIN;

EID: 78049440179     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Altucci L., Gronemeyer H.: The promise of retinoids to fight against cancer. Nat. Rev. Cancer, 2001;1:181-193 (Pubitemid 33741893)
2. Chun K. H., Lotan R.: Higher potency of the synthetic retinoid MX3350-1 compared to the natural all-trans retinoic acid in modulation of cell cycle and induction of apoptosis in head and neck squamous carcinoma cells. Cell Death Differ., 2006;13:1830-1832 (Pubitemid 44390868)
3. Clarke N., Germain P., Altucci L., Gronemever H.: Mode of action of RAR-RXR heterodimers. Expert. Rev. Mol. Med. 2004;6:25-30. http://www. expertreviews.org/ (25.05.2009)
4. Curtin J. C., Dragnev K. H., Sekula D., Christie A. J., Dmitrovsky E., Spinella M. J.: Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 tranactivation function. Oncogene, 2001;20:2559-2569 (Pubitemid 32531353)
5. Degos L., Dombret H., Chomienne C., Daniel M. T, Micléa J. M., Chastang C., Castaigne S., Fenaux P.: All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood, 1995;85:2643-2653
6. Dworakowska D.: Rola białka p53, pRb, P21WAF1/CIP1, PCNA, mdm2 oraz cykliny D1 w regulacji cyklu komórkowego oraz apoptozy Onkol. Pol., 2005;8:223-228
7. El-Metwally T. H., Hussein M. R., Abd-El-Ghaffar S. K., Abo-El-Naga M. M., Ulrich A. B., Pour P. M.: Retinoic acid can induce markers of endocrine transdifferentiation in pancreatic ductal adenocarcinoma: preliminary observations from an in vitro cell line model. J. Clin. Pathol., 2006;59:603-610 (Pubitemid 43886044)
8. El-Metwally T. H., Hussein M. R., Pour P. M., Kuszynski C. A., Adrian T. E.: Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant. Cancer Biol. Ther., 2005;4:474-483 (Pubitemid 41351268)
9. El-Metwally T. H., Pour P. M.: The retinoid induced pancreatic cancer redifferentiation-apoptosis sequence and the mitochondria: a suggested obligatory sequence of events. J. Pancreas, 2007;8:268-278 (Pubitemid 46876785)
10. Falanga A., Consonni R., Marchetti M., Locatelli G., Garattini E., Passerini C. G., Gordon S. G., Barbui T.: Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood, 1998;92:143-151 (Pubitemid 28303186)
11. Falanga A., Rickles F. R.: Management of thrombohemorrhagic syndromes (THS) in hematologic malignancies. Hematology Am. Soc. Hematol. Educ. Program, 2007;165-171
12. Falanga A., Rickles F. R.: Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. Best Pract. Res. Clin. Haematol., 2003;16:463-482
13. Falanga A., Toma S., Marchetti M., Palumbo R., Raffo P., Consonni R., Marziali S., Dastoli G., Barbui T.: Effect of all-trans-retinoic acid on the hypercoagulable state of patients with breast cancer. Am. J. Hematol., 2002;70:9-15
14. Farooqui A. A., Antony P., Ong W. Y., Horrocks L. A., Freysz L.: Retinoic acid-mediated phospholipase A2 signaling in the nucleus. Brain Res. Brain Res. Rev., 2004;45:179-195 (Pubitemid 38802870)
15. Gianni M., Ponzanelli I., Mologni L., Reichert U., Rambaldi A., Terao M., Garattini E.: Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases. Cell Death Differ., 2000;7:447-460 (Pubitemid 30255713)
16. Gottlieb R. A.: Programmed cell death. Drug News Perspect., 2000;13:471-476 (Pubitemid 32063585)
17. Guo J., Xiao B., Lou Y., Yan C., Zhan L., Wang D., Zhao W.: Antitumor effects of all-trans-retinoic acid on cultured human pancreatic cancer cells. J. Gastroenterol. Hepatol., 2006, 21:443-448
18. Guo J. M., Xiao B. X., Lou Y. R., Wang D. H., Yan C. H., Zhan L., Zhao W. H.: The effects of all-trans-retinoic acid on cell cycle and alkaline phosphatase activity in pancreatic cancer cells. Med. Chem., 2006;2:457-461 (Pubitemid 44383216)
19. Hellman A., Prejzner W: Białaczki - rozpoznawanie i leczenie. Przew. Lek., 2001;4:14-21
20. Izdebska M., Grzanka A., Ostrowski M.: Reorganizacja cytoszkieletu, a różnicowanie siȩ komórek linii ludzkich białaczek HL-60 i K-562. Postepy Hig. Med. Dosw., 2006;60:64-70
21. Lee C. H., Wei L. N.: Characterization of the mouse nuclear orphan receptor TR2-11 gene promoter and its potential role in retinoic acidinduced P19 apoptosis. Biochem. Pharmacol., 2000;60:127-136
22. Leszczyniecka M., Roberts T., Dent P., Grant S., Fisher P. B.: Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol. Ther., 2001;90:105-156 (Pubitemid 32926714)
23. Li J., Orr B., White K., Belogortseva N., Niles R., Boskovic G., Nguyen H., Dykes A., Park M.: Chmp 1A is a mediator of the anti-βroliferative effects of all-trans retinoic acid in human pancreatic cancer cells. Mol. Cancer, 2009;8:7
24. Liu S., Wu Q., Chen Z. M., Su W. J.: The effect pathway of retinoic acid through regulation of retinoic acid receptor a in gastric cancer cells. World J. Gastroenterol., 2001;7:662-666 (Pubitemid 32994416)
25. Lotan R.: Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Anticancer Res., 1996;16:2415-2419 (Pubitemid 26325424)
26. Lutz J. D., Dixit V., Yeung C. K., Dickmann L. J., Zelter A., Thatcher J. E., Nelson W. L., Isoherranen N.: Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase. Biochem. Pharmacol., 2009;77:258-268
27. Marchetti M., Vignoli A., Bani M. R., Balducci D., Barbui T., Falanga A.: All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties. Haematologica, 2003;88:895-905 (Pubitemid 37128089)
28. Miller W. H. Jr., Moy D., Li A., Grippo J. F, Dmitrovsky E.: Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in human embryonal cancer cell line. Oncogene, 1990;5:511-517
29. Olins A. L., Herrmann H., Lichter P., Olins D. E.: Retinoic acid differentiation of HL-60 cells promotes cytoskeletal polarization. Exp. Cell Res., 2000;254:130-142 (Pubitemid 30066739)
30. Opiela J., Ka̧tska-Ksia̧żkiewicz L.: Rola białek rodziny BCL-2 w kontroli apoptozy w pȩcherzykach jajnikowych. Biotechnologia, 2006;1:90-96
31. Oridate N., Esumi N., Lotan D., Hing W. K., Rochette-Egly C., Chambon P., Lotan R.: Implication of retinoic acid receptor γ in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells. Oncogene, 1996;12:2019-2028 (Pubitemid 26154674)
32. Osanai M., Petkovich M.: Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Mol. Pharmacol., 2005;67:1808-1817 (Pubitemid 40594182)
33. Park E. Y., Wilder E. T., Lane M. A.: Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels. Nutr. Cancer, 2007;57:66-77 (Pubitemid 46871571)
34. Peng X., Yun D., Christov K.: Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids. Int. J. Oncol., 2004;25:961-971
35. Recchia F., Sica G., Candeloro G., Necozione S., Bisegna R., Bratta M., Rea S.: Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: long-term follow-up of phase II study. Oncol. Rep., 2009;21:1011-1016
36. Simoni D., Tolomeo M.: Retinoids, apoptosis and cancer. Curr. Pharm. Des., 2001;7:1823-1837 (Pubitemid 32998338)
37. Sklan D.: Vitamin A in human nutrition. Prog. Food Nutr. Sci., 1987;11:39-55 (Pubitemid 17135107)
38. Skrzycki M., Scibior-Bentkowska D., Podsiad M., Czeczot H.: Poziom białek czynników transkrypcyjnych AP-1 i NF-κB w wybranych nowotworach przewodu pokarmowego człowieka. Pol. Merk. Lek., 2008;25:510-515
39. Soprano D. R., Qin P., Soprano K. J.: Retinoid acid receptors and cancers. Annu. Rev. Nutr., 2004;24:201-221
40. Wang Q., Wieder R.: All-trans retinoic acid potentiates Taxotereinduced cell death mediated by Jun. N-terminal kinase in breast cancer cells. Oncogene, 2004;23:426-433 (Pubitemid 38174997)
41. Wang X. J., Hayes J. D., Henderson C. J., Wolf C. R.: Identifcation of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor α. Proc. Natl. Acad. Sci. USA, 2007;104:19589-19594
42. Wlazlak E., Surkont G., Kobos J., Tylinski W., Stetkiewicz T., Suzin J.: Ekspresja metaloproteinaz MMP-1, MMP-9 oraz tkankowego inhibitora metaloproteinazy TIMP-1 w przypadkach raka endometrium oraz rozrostów błony sluzowej jamy macicy. Przegl. Menopauzalny, 2006;6:363-366 (Pubitemid 46188990)
43. Wu Q., Chen Z., Su W.: Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression. Chin. Med. J., 2001;114:958-961 (Pubitemid 32911088)
44. Wu Q., Chen Z. M., Su W. J.: Anticancer effect of retinoic acid via AP-1 activity repression is mediates by retinoic acid receptor a and β in gastric cancer cells. Int. J. Biochem. Cell Biol., 2002;34:1102-1114 (Pubitemid 34493771)
45. Yang Q., Sakurai T., Kakudo K.: Retinoid, retinoic acid receptor p and breast cancer. Breast Cancer Res. Treat., 2002;76:167-173 (Pubitemid 35252494)
46. Ye X., Wu Q., Liu S., Lin X., Zhang B., Wu J., Cai J., Zhang M., Su W.: Distinct role and functional mode of TR3 and RARa in mediating ATRA-induced signalling pathway in breast and gastric cancer cells. Int. J. Biochem. Cell Biol., 2004;36:98-113 (Pubitemid 37338476)
47. Yu Z., Han J., Lin J., Xiao Y., Zhang X., Li Y.: Apoptosis induced by at RA in MEPM cells is mediated through activation of caspase and RAR. Toxicol. Sci., 2006;89:504-509 (Pubitemid 43126009)
48. Zhang H., Rosdahl I.: Expression profiles of p53, p21, bax and bcl-2 proteins in all-trans-retinoic acid treated primary and metastatic melanoma cells. Int. J. Oncol., 2004;25:303-308
49. Zhang H., Satyamoorthy K., Herlyn M., Rosdahl I.: All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells - a speculation on damage effect of at RA via mitochondrial dysfunction and cell cycle redistribution. Carcinogenesis, 2003;24:185-191 (Pubitemid 36267085)
50. Zhang J. P., Chen X. Y., Li J. S.: Effects of all-trans-retinoic on human gastric cancer cells BGC-823. J. Dig. Dis., 2007;8:29-34 (Pubitemid 46189207)
51. Zhang X. K., Liu Y., Lee M. O.: Retinoid receptors in human lung cancer and breast cancer. Mutat. Res., 1996;350:267-277 (Pubitemid 26072418)
52. Zou C. P, Clifford J. L., Xu X. C., Sacks P. G., Chambon P., Hong W. K., Lotan R.: Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res., 1994;54:5479-5487 (Pubitemid 24336044)
53. Zou C. P., Hong W. K., Lotan R.: Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells. Differentiation, 1999;64:123-132 (Pubitemid 29077839)
54. Żaba R.: Bezpieczenstwo stosowania retinoidów. Postepy Dermatol. Alergol., 2006;23:161-174